NCT00654316View on ClinicalTrials.gov

Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
TB
Interventions
BIOLOGICAL

BCG

intradermal injection of 0.1ml BCG over the deltoid muscle

Trial Locations (1)

OX3 7LJ

Centre for Clinical Vaccinology and Tropical Medicine, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT00654316 - Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine | Biotech Hunter | Biotech Hunter